1. Home
  2. GSHD vs ANIP Comparison

GSHD vs ANIP Comparison

Compare GSHD & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Goosehead Insurance Inc.

GSHD

Goosehead Insurance Inc.

HOLD

Current Price

$66.17

Market Cap

1.9B

Sector

Finance

ML Signal

HOLD

ANIP

ANI Pharmaceuticals Inc.

HOLD

Current Price

$81.84

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GSHD
ANIP
Founded
2003
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Specialty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
2.0B
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
GSHD
ANIP
Price
$66.17
$81.84
Analyst Decision
Buy
Strong Buy
Analyst Count
11
6
Target Price
$95.73
$107.33
AVG Volume (30 Days)
259.3K
548.1K
Earning Date
02-23-2026
02-27-2026
Dividend Yield
N/A
N/A
EPS Growth
68.12
N/A
EPS
1.14
1.67
Revenue
$353,231,000.00
$826,880,000.00
Revenue This Year
$16.89
$44.35
Revenue Next Year
$18.89
$11.13
P/E Ratio
$56.34
$48.66
Revenue Growth
25.01
48.87
52 Week Low
$59.53
$54.10
52 Week High
$127.99
$99.50

Technical Indicators

Market Signals
Indicator
GSHD
ANIP
Relative Strength Index (RSI) 43.06 49.82
Support Level $59.53 $78.79
Resistance Level $66.26 $83.80
Average True Range (ATR) 2.79 2.63
MACD -0.10 -0.11
Stochastic Oscillator 43.86 41.54

Price Performance

Historical Comparison
GSHD
ANIP

About GSHD Goosehead Insurance Inc.

Goosehead Insurance Inc operates as an insurance agency. Its insurance products consist of homeowner's insurance; auto insurance; other personal lines products including flood, wind and earthquake insurance; excess liability or umbrella insurance; specialty lines insurance (motorcycle, recreational vehicle and other insurance); commercial lines insurance (general liability, property, and auto insurance for small businesses); and life insurance. Geographically, it operates in Texas, California, Illinois, Florida, and other regions.

About ANIP ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid-dose products. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended-release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. The company operates in two segments which include Rare Diseases and Brands, Generics, and Others. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.

Share on Social Networks: